PharmaCielo Ltd.
PCLO.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.31M | -10.43M | -11.22M | -12.06M | -9.51M |
| Total Depreciation and Amortization | 129.40K | 418.00K | 649.50K | 826.20K | 185.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.64M | 6.04M | 5.29M | 5.78M | 5.18M |
| Change in Net Operating Assets | 1.16M | 1.32M | 1.89M | 1.52M | 102.50K |
| Cash from Operations | -2.39M | -2.66M | -3.40M | -3.94M | -4.04M |
| Capital Expenditure | -3.90K | -4.30K | -2.30K | -11.30K | -53.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 198.00K | 241.20K | 282.80K | 424.60K | 452.70K |
| Cash from Investing | 194.10K | 236.90K | 280.60K | 413.40K | 399.40K |
| Total Debt Issued | 2.80M | 3.65M | 4.48M | 5.45M | 5.21M |
| Total Debt Repaid | -856.40K | -862.70K | -801.20K | -816.70K | -717.00K |
| Issuance of Common Stock | 1.03M | 425.00K | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 237.00K | -- | 40.00K |
| Cash from Financing | 2.19M | 2.37M | 2.90M | 3.43M | 3.35M |
| Foreign Exchange rate Adjustments | 7.50K | 7.40K | 7.00K | 14.00K | -15.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.20K | -47.90K | -212.20K | -84.40K | -298.60K |
